Improved HIV-1 RNA quantitation by COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test, v2.0 using a novel dual-target approach

Journal of Clinical Virology

Volumn 49, Issue 1, 2010, Pages 41-46

  Sizmann, Dorothea ^a   Glaubitz, Joachim ^a   Simon, Christian O ^a   Goedel, Sebastian ^a   Buergisser, Philippe ^d   Drogan, Daniel ^a   Hesse, Martin ^a   Kröh, Michael ^a   Simmler, Pascale ^a   Dewald, Manuela ^a   Gilsdorf, Marion ^a   Fuerst, Marion ^a   Ineichen, Ralph ^a   Kirn, Anette ^a   Pasche, Paul ^a   Wang, Zhijun ^b   Weisshaar, Sabrina ^a   Young, Karen ^c   Haberhausen, Gerd ^a   Babiel, Reiner ^a  

^a Roche Diagnostics Ltd   (Switzerland)

^b HOFFMANN LA ROCHE INC   (United States)

^c ROCHE MOLECULAR SYSTEMS   (United States)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Automation; Dual target; HIV; Quantitation; Real time PCR

Indexed keywords

VIRUS RNA;

ARTICLE; DIAGNOSTIC ACCURACY; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; LABORATORY APPARATUS, EQUIPMENT AND SUPPLIES; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; VIRUS DIAGNOSIS;

EID: 77955652621     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2010.06.004     Document Type: Article

References (19)

1. Barré-Sinoussi F., Chermann J.C., Rey F., Nugeyre M.T., Chamaret S., Gruest J., et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 1983, 220:868-871.
2. Popovic M., Sarngadharan M.G., Read E., Gallo R.C. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 1984, 224:497-500.
3. Curran J.W., Jaffe H.W., Hardy A.M., Morgan W.M., Selik R.M., Dondero T.J. Epidemiology of HIV infection and AIDS in the United States. Science 1988, 239:610-616.
4. Kassutto S., Rosenberg E.S. Primary HIV type 1 infection. Clin Infect Dis 2004, 38:1447-1453.
5. Clark S.J., Saag M.S., Decker W.D. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N Engl J Med 1991, 324:954-960.
6. Klimas N., O'Brien Koneru A., Fletcher M.A. Overview of HIV. Psychosom Med 2008, 70:523-530.
7. ® TaqMan HIV-1 assays. J Clin Microbiol 2007, 45:3436-3438.
8. Wu J.H., Hong P.Y., Liu W.T. Quantitative effects of position and type of single mismatch on single base primer extension. J Microbiol Methods 2009, 77(3):267-275.
9. Kwok S., Sninsky J.J. PCR detection of human immunodeficiency virus type 1 proviral DNA sequences. Diagnostic molecular biology: principles and applications 1993, ASM Press, Washington, DC. D.H. Persing, T.F. Smith, F.C. Smith, T.J. Tenover, T.J. White (Eds.).
10. Laprevotte I., Pupin M., Coward E., Didier G., Terzian C., Devauchelle C., et al. HIV-1 and HIV-2 LTR nucleotide sequences: assessment of the alignment by N-block presentation, " retroviral signatures" of overrepeated oligonucleotides, and a probable important role of scrambled stepwise duplications/deletions in molecular evolution. Mol Biol Evol 2001, 18:1231-1245.
11. Holmes H., Davis C., Heath A., Hewlett I., Lelie N. An international collaborative study to establish the 1st international standard for HIV-1 RNA for use in nucleic acid-based techniques. J Virol Methods 2001, 92:141-150.
12. ® system. J Clin Virol 2007, 38:304-312.
13. Davis C., Berry N., Heath A., Holmes H. An international collaborative study to establish a replacement World Health Organization International Standard for human immunodeficiency virus 1 RNA nucleic acid assays. Vox Sanguinis 2008, 95:218-225.
14. Gürtler L.G., Hauser P.H., Eberle J., von Brunn A., Knapp S., Zekeng L., et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994, 68:1581-1585.
15. Thomson M.M., Najera R. Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: an update. AIDS Rev 2005, 7:210-224.
16. Alaeus A., Lidman K., Sönnerborg A., Albert J. Subtype-specific problems with quantification of plasma HIV-1 RNA. AIDS 1997, 11:859-865.
17. Swanson P., Devare S.G., Hackett J. Molecular characterization of 39 HIV-1 isolates representing group M (subtypes A-G) and group O: sequence analysis of gag p24, pol integrase, and env gp41. AIDS Res Hum Retroviruses 2003, 19:625-629.
18. Shen L., Siliciano R.F. Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. J Allergy Clin Immunol 2008, 122:22-28.
19. Maldarelli F., Palmer S., King M.S., Wiegand A., Polis M.A., Mican J.A., et al. ART suppresses plasma HIV-1 RNA to a stable set point predicted by pretherapy viremia. PLoS Pathog 2007, 3:484-488.